2020
DOI: 10.1016/j.jstrokecerebrovasdis.2020.104664
|View full text |Cite
|
Sign up to set email alerts
|

Effectiveness of Paroxetine for Poststroke Depression: A Meta-Analysis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
9
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(9 citation statements)
references
References 14 publications
0
9
0
Order By: Relevance
“…Depression is characterized by high recurrence and disability rates, even leading to suicide (Jacobs, 2003), and lifetime prevalence of depression could reach 15.7% (Keller & Berndt, 2002). The preferred treatment is medication, especially selective serotonin reuptake inhibitors (Zhao et al, 2019), such as fluoxetine (Macías-Cortés et al, 2013), paroxetine (Li et al, 2020), and sertraline (Padmapriya et al, 2020), which are mainstream antidepressants. However, antidepressants are prone to drug resistance and side effects (Högberg, 2014;Howland, 2007), and long-term treatment has limited effectiveness accompanied by a high recurrence rate (Fond, 2015), which can easily lead to patient non-compliance.…”
Section: Introductionmentioning
confidence: 99%
“…Depression is characterized by high recurrence and disability rates, even leading to suicide (Jacobs, 2003), and lifetime prevalence of depression could reach 15.7% (Keller & Berndt, 2002). The preferred treatment is medication, especially selective serotonin reuptake inhibitors (Zhao et al, 2019), such as fluoxetine (Macías-Cortés et al, 2013), paroxetine (Li et al, 2020), and sertraline (Padmapriya et al, 2020), which are mainstream antidepressants. However, antidepressants are prone to drug resistance and side effects (Högberg, 2014;Howland, 2007), and long-term treatment has limited effectiveness accompanied by a high recurrence rate (Fond, 2015), which can easily lead to patient non-compliance.…”
Section: Introductionmentioning
confidence: 99%
“…In all, 19 studies were excluded due to the following reasons: No necessary sample data ( n = 8), Other outcomes ( n = 5), Other reviews ( n = 4), and Other languages ( n = 2) ( Figure 1 ). Thus, 17 studies were included in the umbrella review (Yi et al, 2010 ; Eng and Reime, 2014 ; Ren et al, 2015 ; Tan et al, 2015 ; Feng et al, 2018 , 2022 ; Jin et al, 2018 ; Wang et al, 2018 , 2021 ; Liu et al, 2019 , 2021 ; Li et al, 2020 ; Cai et al, 2021 ; Lee et al, 2021 ; Zhang et al, 2021a , b ; Guo et al, 2022 ). Study characteristics and quality ratings of 17 meta-analyses/systematic reviews were summarized in Table 1 .…”
Section: Resultsmentioning
confidence: 99%
“…The rat was placed in the center of the box. After the 5-min test, the number of squares crossed by the four paws of the rat was the horizontal score, and the number of standing hind limbs was the vertical score [ 13 ] . After the test of each rat was finished, the bottom surface of the square box was cleaned to prevent the remaining information of the animal from the previous test (such as the animal's urine and feces) from affecting the next test result.…”
Section: Methodsmentioning
confidence: 99%
“…At present, the treatment of PSD is mainly based on the tricyclic and tetracyclic drugs used in the monoamine hypothesis of depression, as well as norepinephrine and serotonin reuptake inhibitors [ 12 , 13 ]. Among them, selective serotonin reuptake inhibitors and tricyclic antidepressants are the two most widely studied drugs, and their antidepressant effects were found to be related to the improvement of synaptic plasticity [ 14 ].…”
Section: Introductionmentioning
confidence: 99%